Predictors of Response to Ketamine in Treatment Resistant Major Depressive Disorder and Bipolar Disorder

Objectives: Extant evidence indicates that ketamine exerts rapid antidepressant effects in treatment-resistant depressive (TRD) symptoms as a part of major depressive disorder (MDD) and bipolar disorder (BD). The identification of depressed sub-populations that are more likely to benefit from ketami...

Descripción completa

Detalles Bibliográficos
Autores principales: Rong, Carola, Park, Caroline, Rosenblat, Joshua D., Subramaniapillai, Mehala, Zuckerman, Hannah, Fus, Dominika, Lee, Yena L., Pan, Zihang, Brietzke, Elisa, Mansur, Rodrigo B., Cha, Danielle S., Lui, Leanna M. W., McIntyre, Roger S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5923813/
https://www.ncbi.nlm.nih.gov/pubmed/29673146
http://dx.doi.org/10.3390/ijerph15040771

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5923813/
https://www.ncbi.nlm.nih.gov/pubmed/29673146
http://dx.doi.org/10.3390/ijerph15040771

Ejemplares similares